Galantamine improves sleep quality in patients with dementia

[1]  R. Ownby,et al.  Subtypes of sleep problems in patients with Alzheimer disease. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[2]  Ho-Won Lee,et al.  Effects of Single Treatment of Anti-Dementia Drugs on Sleep-Wake Patterns in Rats , 2012, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[3]  H. Doruk,et al.  Analysis of the efficiencies of galantamine and donepezil on sleep disorder in patients with dementia , 2011 .

[4]  C. Lyketsos,et al.  Treatment of sleep disturbance in Alzheimer's dementia , 2011, International journal of geriatric psychiatry.

[5]  P. Derambure,et al.  Sleep disorders in aging and dementia , 2010, The journal of nutrition, health & aging.

[6]  E. Eşel,et al.  The Effects of Galantamine Hydrobromide Treatment on Dehydroepiandrosterone Sulfate and Cortisol Levels in Patients with Chronic Fatigue Syndrome , 2009, Psychiatry investigation.

[7]  C. Kamei,et al.  [Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats]. , 2009, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.

[8]  Susan M McCurry,et al.  Current treatments for sleep disturbances in individuals with dementia , 2009, Current psychiatry reports.

[9]  Magda Tsolaki,et al.  Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine* , 2008, Current Medical Research and Opinion.

[10]  N. Poungvarin,et al.  The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients. , 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[11]  P. Pregelj,et al.  Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system. , 2008, Psychiatria Danubina.

[12]  C. Guilleminault,et al.  Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. , 2008, Chest.

[13]  Y. Dauvilliers.  Insomnia in patients with neurodegenerative conditions. , 2007, Sleep medicine.

[14]  D. Swaab,et al.  Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. , 2007, Sleep medicine.

[15]  R. Schwarcz,et al.  Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at α7* Nicotinic Receptors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[16]  George P Chrousos,et al.  CHRONIC INSOMNIA AND STRESS SYSTEM. , 2007, Sleep medicine clinics.

[17]  T. Nabeshima,et al.  The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Ameliorates the Cognitive Dysfunction in Beta Amyloid25–35 I.c.v.-Injected Mice: Involvement of Dopaminergic Systems , 2007, Neuropsychopharmacology.

[18]  Christian Guilleminault,et al.  The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. , 2006, Sleep.

[19]  J. Yesavage,et al.  Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission , 2005, Neuroscience.

[20]  S. Ancoli-Israel,et al.  Effects of Galantamine Versus Donepezil on Sleep in Patients With Mild to Moderate Alzheimer Disease and Their Caregivers: A Double-Blind, Head-to-Head, Randomized Pilot Study , 2005, Alzheimer disease and associated disorders.

[21]  H. Geerts,et al.  Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits , 2005, Brain Research.

[22]  B. Boeve,et al.  REM Sleep Behavior Disorder in Parkinson’s Disease and Dementia with Lewy Bodies , 2004, Journal of geriatric psychiatry and neurology.

[23]  S. Stahl,et al.  Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease , 2004, Current medical research and opinion.

[24]  J. Markowitz,et al.  Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. , 2003, Sleep.

[25]  H. Ogura,et al.  Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. , 2000, Methods and findings in experimental and clinical pharmacology.

[26]  R. Blesa.  Galantamine: Therapeutic Effects beyond Cognition , 2000, Dementia and Geriatric Cognitive Disorders.

[27]  M A Stephens,et al.  Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[28]  D J Foley,et al.  Sleep complaints among elderly persons: an epidemiologic study of three communities. , 1995, Sleep.

[29]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[30]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[31]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[32]  H. Bimonte-Nelson,et al.  Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline. , 2010, Progress in brain research.

[33]  C. Kamei,et al.  Characteristic effects of anti-dementia drugs on rat sleep patterns. , 2009, Journal of pharmacological sciences.

[34]  S. Ancoli-Israel,et al.  Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer’s Disease , 2006, Drugs & aging.

[35]  S. Borson,et al.  Sleep Disturbances in Patients with Alzheimer’s Disease , 2001, CNS drugs.

[36]  M. Ağargün,et al.  The Validity and reliability of the Pittsburgh Sleep Quality Index , 1996 .